Ustekinumab: “Real-world” outcomes and potential predictors of nonresponse in treatment-refractory Crohn’s disease

Table 4 Characteristics entering the multivariable logistic regression model

Parameter	OR	95%CI	P value
Male sex	0.112	(0.021; 0.605)	0.011
Extraintestinal manifestations	0.119	(0.022; 0.636)	0.013
HBI at baseline	0.853	(0.718; 1.014)	0.071
Use of steroids (including budesonide) at baseline	0.071	(0.011; 0.464)	0.006

Only variables listed in Table 3 with a univariable P value below 0.1 were considered for logistic regression model. Area under the curve: 91.07% (95%CI = 81.64%-100%).